BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 22, 2002
View Archived Issues
Alkermes Buying Reliant In Stock Purchase Worth $934M
Scooping up the shares it doesn’t already own, Alkermes Inc. agreed to purchase the remaining 81 percent of Reliant Pharmaceuticals LLC in a stock deal worth about $934 million. (BioWorld Today)
Read More
PDL’s Stock Up 22 Percent On Poor Phase II Results
Read More
Test Ships Amyloid-Beta Plaques From Brain To Blood, Forecasts Alzheimer’s Onset Years Ahead
Read More
Ligand, Elan Get FDA Nod For Pain Treatment Avinza
Read More
Other News To Note
Read More
Cell Genesys Drops Gene Therapy Collaboration With GPC Biotech
Read More
Hemosol’s Stock Falls 29 Percent After Hemolink Denial In Canada
Read More